Showing results (61-70 of 710) with videos related to
Sort By:
Pageof 71
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2015
New Strategies in Bladder Cancer: A Second Coming for ImmunotherapyAli Ghasemzadeh, Trinity J Bivalacqua, Noah M Hahn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and VaccinationChristopher M Jackson, Christina M Kochel, Christopher J Nirschl, et al.Neuro-Oncology Advances|September 11, 2025
The glioma microenvironment and its impact on antitumor immunityLandon J Hansen, Christopher M JacksonJournal of Translational Medicine|April 6, 2013
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancerSatoshi Wada, Christopher M Jackson, Kiyoshi Yoshimura, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 15, 2023
Use of tubular retractors to access deep brain lesions: A case seriesMaureen Rakovec, Samantha Camp, David Day, et al.Urologic Oncology|March 1, 2016
Blocking immune checkpoints in prostate, kidney, and urothelial cancer: An overviewAngela K B Alme, Beerinder S Karir, Bishoy M Faltas, et al.Oncoimmunology|November 22, 2012
Combinatorial Immunotherapy: PD-1 may not be LAG-ing behind any moreMeghan E Turnis, Alan J Korman, Charles G Drake, et al.Immunological Reviews|March 5, 2017
LAG3 (CD223) as a cancer immunotherapy targetLawrence P Andrews, Ariel E Marciscano, Charles G Drake, et al.Cancer Immunology Research|August 6, 2014
Cancer immunotherapy highlights from the 2014 ASCO MeetingLauren C Harshman, Charles G Drake, Jennifer A Wargo, et al.Immunology and Cell Biology|March 2, 2011
Resolution of infection promotes a state of dormancy and long survival of CD4 memory T cellsSarat K Dalai, Stanislav Khoruzhenko, Charles G Drake, et al.Pageof 71